In the world of pharmaceutical distribution, standing still is not an option. Regulations evolve, expectations sharpen, and the responsibility carried by Responsible Persons (RPs) continues to grow. Maintaining clarity, confidence, and compliance requires more than experience alone – it requires regular refinement.
The RP Refresher Training course is designed specifically for RPs and Deputy RPs as an annual refresher on the GDP guidelines plus additional areas applicable to RPs and their nominated deputies.
This article provides an overview of the recent MHRA update for UKCA conformity assessment for medical devices, with practical insights for regulatory, quality, and executive teams.
Are your quality and audit team ready for the digital shift? Do they have the right mindset? The tools are there is it time to assess which ones are right for your organisation.
There is a hard stop to the change process, from 1st April the system will be operable, and the products registered at that point will decide the fees payable for 2026/27. So, there are a number of actions manufacturers and UKRPs will need to consider.
To place medical devices onto the UK market manufacturers must register with the MHRA and register all relevant products, registration must be active when each batch of product is placed on the market. For manufacturers based outside the Uk this is done via the UKRP.
